LIMON (Liver Monitoring): An Application for Patients with Fatty LiverAref, MohadeseChoobin, NiloofarTab, AsmaJournal of Biomedical Physics & Engineering
Co-author Dr. Jonathan Catling, from the University of Birmingham, commented, "Finding an increased prevalence ofpersonality disordersin NAFLD patients is particularly striking—signifying that it's not an issue associated with all liver disease, but just those with NAFLD. "Importantly, it appears n...
The influence of hepatic steatosis (HS) on liver metastasis in patients with non-metastatic breast cancer (BC) remains unclear. The aim of this study was to clarify the relationship between HS and liver metastasis in non-metastatic BC patients. Patients who underwent treatment for BC at two aff...
Patients that have non-alcoholic fatty liver disease often show signs of elevated levels of harmful transaminase enzymes in the liver (also known as AST and ALT). According to a 2012studyconducted at the Gastrointestinal and Liver Clinic of Qazvin in central Iran licorice was found to help brin...
Background: To assess the prevalence, risk factors, clinical characteristics of Acute fatty liver of pregnancy (AFLP) patients, and outcomes of AFLP patients treated with plasma exchange (PE). Methods: We retrospectively reviewed the AFLP patients admitted to the First Affiliated Hospital of Xi'an...
Challenges for patients with NAFLD: a patient perspective Despite the growing burden of fatty liver diseases, patients still report delays in receiving a diagnosis, indicating a general lack of disease awareness or the ability of health professionals to communicate information in ways that can be unde...
Liver to Healthy Liver,”is now available for purchase. This complete guide brings together all the knowledge and experience I’ve accumulated over the years, making itTHEmust-have resource for anyone looking to reverse their fatty liver disease. Written by a former patient for current patients....
Fatty liver index and cardiovascular outcomes in never-treated hypertensive patients: a prospective cohort. Hypertens Res. 2023;46:119–27. Article PubMed Google Scholar Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The fatty liver index: a simple and...
WASHINGTON — In this exclusive video from Emerging Trends in Non-Alcoholic Fatty Liver Disease, Arun Sanyal, MD, FAASLD, of the Virginia Commonwealth University, discusses racial differences related to the risk for deve...
(T2DM)2. A recent study in the United States population has reported the presence of NAFLD in up to 78–85% of patients with T2DM, based on the use of different non-invasive markers of liver steatosis3. Specifically in Spain, the prevalence of NAFLD has been estimated to be 26% among ...